Find disease awareness content and relevant supporting materials
Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke (AIS) is contraindicated in patient taking either Factor Xa inhibitors or direct thrombin inhibitors.
Medical treatment for spontaneous anticoagulation-related intracerebral hemorrhage in the Netherlands
Spontaneous anticoagulation-related intracerebral hemorrhage accounts for up to a quarter of spontaneous intracerebral hemorrhage cases and is associated with higher hematoma volume and a worse outcome.
Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study
Objective: To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke. Design: A cross-sectional...
Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke.
With changing prescription practice, among other factors, clinicians can expect to see rising numbers of patients with ischemic stroke and pre-existing NOAC therapy. Few data exist regarding a potential impact of NOAC on stroke severity and outcome.